欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PL/H/0858/002
药品名称
Lapress
活性成分
lercanidipine hydrochloride 20.0 mg
剂型
Film-coated tablet
上市许可持有人
S-LAB Sp. z o.o. ul. Kiełczowska 2 55-095 Mirków Poland
参考成员国 - 产品名称
Poland (PL)
互认成员国 - 产品名称
Denmark (DK)
许可日期
2020/12/17
最近更新日期
2023/08/11
药物ATC编码
C08CA13 lercanidipine
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Product Information
|
Lercanidipine_PI Day 160 15_Oct_2020 _ clean
Date of last change:2024/09/06
PubAR
|
PAR Lapress_ film coated tablet 10 mg and 20 mg_ DK_H_3192_001_002_DC
Date of last change:2024/09/06
PubAR Summary
|
sPAR Lapress_ film coated tablet 10 mg and 20 mg_ DK_H_3192_001_002_DC
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase